2024
P10.25.A STANDARDIZATION AND AUTOMATIZATION OF MEASURING AND REPORTING BRAIN METASTASIS OVER TIME BY LEVERAGING ARTIFICIAL INTELLIGENCE
Weiss D, Bousabarah K, Deuschl C, Chadha S, Ashraf N, Ramakrishnan D, Moawad A, Osenberg K, Schoenherr S, Lautenschlager J, Holler W, Westerhoff M, Schrickel E, Memon F, Moily N, Malhotra A, Lin M, Aboian M. P10.25.A STANDARDIZATION AND AUTOMATIZATION OF MEASURING AND REPORTING BRAIN METASTASIS OVER TIME BY LEVERAGING ARTIFICIAL INTELLIGENCE. Neuro-Oncology 2024, 26: v61-v61. PMCID: PMC11485790, DOI: 10.1093/neuonc/noae144.201.Peer-Reviewed Original ResearchReports of brain metastasesBrain metastasesInter-observer variabilityFollow-up imaging of patientsPost-Gamma knife radiosurgeryBrain tumorsRANO-BM criteriaFollow-up imagingBoard-certified neuroradiologistsTreatment response monitoringMean Dice coefficientImages of patientsNnU-Net segmentationManual diameter measurementsBM evaluationRANO-BMRetrospective studyTreatment regimenSpearman correlation coefficientInter-rater variabilityMRI reportsIdentified lesionsPercentual changePost-gammaNeuroradiologists
2022
MR Imaging Biomarkers for the Prediction of Outcome after Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessments of the Liver Imaging Reporting and Data System and Radiomic Features
Petukhova-Greenstein A, Zeevi T, Yang J, Chai N, DiDomenico P, Deng Y, Ciarleglio M, Haider SP, Onyiuke I, Malpani R, Lin M, Kucukkaya AS, Gottwald LA, Gebauer B, Revzin M, Onofrey J, Staib L, Gunabushanam G, Taddei T, Chapiro J. MR Imaging Biomarkers for the Prediction of Outcome after Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessments of the Liver Imaging Reporting and Data System and Radiomic Features. Journal Of Vascular And Interventional Radiology 2022, 33: 814-824.e3. PMID: 35460887, PMCID: PMC9335926, DOI: 10.1016/j.jvir.2022.04.006.Peer-Reviewed Original ResearchConceptsProgression-free survivalPoor progression-free survivalLiver Imaging ReportingHepatocellular carcinomaMR imaging biomarkersRadiomics signatureRadiofrequency ablationRadiomic featuresImaging biomarkersImaging ReportingFirst follow-up imagingMedian progression-free survivalRF ablationEarly-stage hepatocellular carcinomaPretreatment magnetic resonanceFirst-line treatmentMultifocal hepatocellular carcinomaSelection operator Cox regression modelTherapy-naïve patientsEarly-stage diseaseKaplan-Meier analysisCox regression modelLog-rank testFollow-up imagingPrediction of outcome